scholarly journals Reduction of central neuropathic pain with ketamine infusion in a patient with Ehlers–Danlos syndrome: a case report

2016 ◽  
Vol Volume 9 ◽  
pp. 683-687 ◽  
Author(s):  
Tony Chung Tung Lo ◽  
Stephen Yeung ◽  
Sujin Lee ◽  
Kira Skavinski ◽  
Solomon Liao
2018 ◽  
Vol 2018 ◽  
pp. 1-4 ◽  
Author(s):  
Garret Weber ◽  
JuHan Yao ◽  
Shemeica Binns ◽  
Shinae Namkoong

Chronic neuropathic pain and depression are often comorbid. Ketamine has been used to treat refractory pain. There is emerging evidence for use in depression. We present a case of a pediatric patient who was successfully treated with subanesthetic intravenous ketamine infusion for chronic neuropathic pain and suicidality.


2010 ◽  
Vol 4 (S1) ◽  
pp. 106-106
Author(s):  
A. Tzortzopoulou ◽  
A. Kolotoura ◽  
A. Alexandropoulou ◽  
G. Provataki ◽  
E. Anastasiou ◽  
...  

2012 ◽  
Vol 30 (1) ◽  
pp. 53-55 ◽  
Author(s):  
David J Kopsky ◽  
Jan M Keppel Hesselink

Central neuropathic pain is a common debilitating symptom in patients with multiple sclerosis. Side effects of analgesics often limit reaching therapeutic dosages. In this case report, a 61-year-old woman with chronic central neuropathic pain due to multiple sclerosis is described. Acupuncture could only partly and temporarily reduce the pain. However, after adding the natural compound palmitoylethanolamide, a glial modulator and peroxisome proliferator-activated receptor-α agonist, pain reduction was more pronounced and the interval between acupuncture sessions could be increased. A multimodal stepped care approach is demonstrated, with acupuncture and palmitoylethanolamide both influencing non-neuronal cells, such as activated glial cells, which are key factors in the development and maintenance of neuropathic pain.


2004 ◽  
Vol 17 (2) ◽  
pp. 248
Author(s):  
Chul Ho Woo ◽  
Sung Ha Mun ◽  
Soo Yeon Lee ◽  
Tae Hyung Han ◽  
Hyun Soo Kim ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document